Cardiovascular - Preclinical (3)
|
Modality |
Indication |
Targets |
Stage |
Company |
Project No. |
Detail |
| 1 |
Non-clinical development of novel target PRDX-based treatment for pulmonary arterial hypertension |
| Small molecules |
Pulmonary Arterial Hypertension |
Peroxiredoxin II (PRDX2) |
Preclinical |
VASTHERA Co. Ltd. |
RS-2024-00338193 |
|
| 2 |
Cell-penetrating antagomir for acute myocardial infarction (nonclinical study) |
| Gene & Nucleic acids |
Myocardial infarction |
miRNA (miR-145 억제) |
Preclinical |
RegenInnopharm Inc |
RS-2024-00333652 |
|
| 3 |
Nonclinical Development of PP1 Targeting Drug for Pulmonary Arterial Hypertension |
| rProtein |
Pulmonary hypertension |
PP1 |
Preclinical |
NadianBio |
HN21C1316 |
|